恶性腹膜肿瘤的影像学
本文综述恶性腹膜肿瘤的影像学表现,涵盖原发与继发性腹膜恶性肿瘤,包括间皮瘤、原发性浆液性腹膜癌及胃肠、妇科和腹外来源的转移性肿瘤。文章强调影像在诊断、分期、再分期、疗效监测及患者选择中的关键作用,并介绍「PAUSE」框架,涉及腹膜癌指数评估肿瘤负荷、治疗前后评估、并发症检测及预后预测,同时讨论CT、MRI、PET/CT和PET/MRI的应用价值及鉴别诊断。
要点
- 影像在恶性腹膜肿瘤多学科管理中用于诊断、分期、再分期和疗效监测。
- 患者选择可采用「PAUSE」框架,包括腹膜癌指数评估肿瘤负荷、治疗前后评估、并发症检测和预后预测。
- CT、MRI、PET/CT和PET/MRI在恶性腹膜肿瘤的决策与管理中具有重要作用。
核心结论
- 影像在恶性腹膜肿瘤的多学科管理中至关重要,有助于诊断、分期、再分期、疗效监测和患者选择,CT、MRI、PET/CT和PET/MRI对有效决策和管理具有重要价值。
研究设计与样本
- 综述,探讨恶性腹膜肿瘤的影像学表现、鉴别诊断及CT、MRI、PET/CT和PET/MRI在决策与管理中的作用。
关键影像表现/征象
- 恶性腹膜肿瘤包括原发肿瘤如间皮瘤和原发性浆液性腹膜癌,以及来自胃肠道、妇科和腹外来源的继发性肿瘤。
- 影像表现需与多种类似病变相鉴别。
临床应用与阅片要点
- 影像用于恶性腹膜肿瘤的诊断、分期、再分期和疗效监测。
- 采用「PAUSE」框架进行患者选择,包括通过腹膜癌指数评估肿瘤负荷、治疗前后评估、治疗后并发症检测和预后预测。
- CT、MRI、PET/CT和PET/MRI可用于恶性腹膜肿瘤的决策与管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Peritoneal malignancies encompass a diverse range of tumors originating within the peritoneum, including primary tumors such as mesothelioma and primary serous peritoneal carcinoma or secondary tumors resulting from the spread of cancers from gastrointestinal, gynecological, and extra-abdominal sources. The traditional approach of palliative care for these malignancies is being replaced by a multimodal strategies that integrates surgery with systemic or intraperitoneal chemotherapy. Notably, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy has shown significant improvements in survival rates. Imaging is crucial in the multidisciplinary management of these tumors, aiding in diagnosis, staging, restaging, and monitoring therapy response. It is also vital for appropriate patient selection, using the acronym "PAUSE", which involves assessing tumor burden via the peritoneal carcinomatosis index, evaluating patients pre- and post-therapy, detecting complications following therapy, and predicting treatment outcomes. This review explores the imaging manifestations of peritoneal malignancies, distinguishing them from various mimics, and underscores the importance of imaging modalities such as CT, MRI, PET/CT, and PET/MRI in effective decision-making and management.
引用
- Srinivas Rao S, Ghosh S, Vardar BU, et al. Imaging in malignant peritoneal neoplasms. Abdom Radiol (NY). 2024. PMID: 39368001. doi:10.1007/s00261-024-04595-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。